The Centers for Disease Control and Prevention has updated its interim guidance for health care professionals for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. The guidance includes criteria for who should be evaluated for MERS-CoV, which have been updated to include individuals with fever and pneumonia or acute respiratory distress syndrome who have a history of being in a health care facility as a patient, worker or visitor in South Korea within 14 days of symptom onset. The guidance also contains guidelines for the evaluation and management of close contacts, as well as reporting, laboratory testing and infection control. CDC said it will update the infection control guidance in the coming days. MERS-CoV, which can be fatal, was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including South Korea, where an outbreak was first reported in May. For more, including common signs and symptoms, see the CDC’s MERS webpage

Related News Articles

Headline
Caitlin Gillooley, AHA director of quality and behavioral health policy, and Evelyn Ivy Mwangi, M.D., Luminis Health Anne Arundel Medical Center geriatric…
Headline
All 50 states have applied for the Rural Health Transformation Program, the Centers for Medicare & Medicaid Services announced Nov. 5. The program will…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder…
Headline
There have been 1,681 confirmed cases of measles in the U.S. so far this year, according to the latest Centers for Disease Control and Prevention data. Cases…
Headline
In the final episode of a four-part series with the Association for Healthcare Philanthropy, CommonSpirit Health’s Daniel Morissette, senior executive vice…